Business description: Nectar Lifesciences Limited

Nectar Lifesciences Limited is an India-based pharmaceutical company. The Company's business areas include active pharmaceutical ingredients (APIs) and intermediates, formulations/finished dosage formulations (FDF), menthol and mint derivatives, and empty hard gelatin capsules. The Company is engaged in the manufacturing of oral and sterile cephalosporin products. Its oral cephalosporins include cefixime, cefurozime axetil crystalline, cefuroxime axetil amorphous, cedpodoxime proxetil, cefprozil and cefdinir. Its sterile cephalosporins include cefotaxime sodium, ceftriaxone sodium, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate and cefepime arginine. Its capacities include cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium and ceftriaxone sodium. The Company offers contract manufacturing capabilities for solid dosage forms, such as tablets, capsules, dry powder oral suspension and granules and injectable for cephalosporins.

Number of employees: 111

Sales by Activity: Nectar Lifesciences Limited

Fiscal Period: March 2022 (INR) 2023 (INR) 2024 (INR) 2025 (INR) 2026 (INR)

Pharmaceuticals Products

16.69B 15.24B 16.85B 16.7B -

Geographical breakdown of sales: Nectar Lifesciences Limited

Fiscal Period: March 2022 (INR) 2023 (INR) 2024 (INR) 2025 (INR) 2026 (INR)

India

11.81B 8.45B 11.46B 11.72B -

Outside India

7.45B 9.01B 7.79B 7.37B -

Executive Committee: Nectar Lifesciences Limited

Manager TitleAgeSince
Director of Finance/CFO 68 14/11/2022
Compliance Officer - 01/04/2025

Composition of the Board of Directors: Nectar Lifesciences Limited

Director TitleAgeSince
Chairman 66 27/06/1995
Director/Board Member 69 11/02/2019
Director/Board Member 75 21/09/2021
Director/Board Member 61 02/08/2022

Shareholders: Nectar Lifesciences Limited

NameStocks%Valuation
28.75 %
55,845,600 28.75 % 7 M ₹
22.46 %
43,622,400 22.46 % 6 M ₹
2.051 %
3,984,829 2.051 % 522 889 ₹
0.6375 %
1,238,448 0.6375 % 162 509 ₹
Government of India
0.0687 %
133,413 0.0687 % 17 506 ₹

Company details: Nectar Lifesciences Limited

Nectar Lifesciences Ltd.

SCO 38-39, Madhya Marg

160009, Chandigarh

+

http://www.neclife.com
address Nectar Lifesciences Limited(NECLIFE)

Generic Pharmaceuticals

Change 5-day change 1-year change 3-year change Capi.($)
-3.60%-5.66%-27.12%-54.18% 23.38M
-1.13%-3.11%+13.82%+60.66% 46.21B
-1.13%-5.78%+33.26%+108.13% 38.78B
+0.12%-0.08%+7.12%+78.27% 11.68B
-0.53%-1.37%-13.25%+10.18% 11.55B
-0.38%-2.26%+18.18%+139.63% 9.14B
+0.32%-2.26%+23.08%+34.73% 7.3B
+0.17%-0.74%+13.44%+197.13% 7.15B
-1.00%-5.25%+34.34%-19.63% 7.1B
-3.13%-4.30%-44.88%+11.66% 4.97B
Average -1.03%-2.90%+5.80%+56.66% 14.39B
Weighted average by Cap. -0.86%-3.27%+16.05%+75.64%
  1. Stock Market
  2. Stocks
  3. NECLIFE Stock
  4. Company Nectar Lifesciences Limited
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!